Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica ›› 2018, Vol. 40 ›› Issue (4): 556-562.doi: 10.3881/j.issn.1000-503X.9793

• Review Articles • Previous Articles     Next Articles

Psoriasis,Cardiovascular Disease,and Adipokines

YU Xiaoling, WU Chao, JIN Hongzhong()   

  1. Department of Dermatology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China
  • Received:2017-05-26 Online:2018-08-30 Published:2018-09-08
  • Supported by:
    Supported by the Beijing Municipal Natural Sciences Foundation (7152117)


Psoriasis usually combines with metabolic diseases,and the prevalence of cardiovascular disease remarkably increases in psoriatic patients. Adipokines,which play an important role in the cardiovascular diseases,also express abnormally in psoriasis and may induce or exacerbate the skin lesion. The adipokines associated with psoriasis and cardiovascular disease include adiponectin,leptin,resistin,omentin,visfatin,chemerin,and retinoid binding protein 4 (RBP-4). The levels of adiponectin and omentin apparently decrease in psoriatic patients compared to healthy controls,and thus they may play protective roles for psoriasis. Similarly,adiponectin plays a protective role in cardiovascular disease,but the role of retina in cardiovascular disease is still controversial. However,the concentrations of leptin,resistin,visfatin,chemerin,and RBP-4 in patients with psoriasis or cardiovascular disease are significantly higher than those of the controls;therefore,they may serve as the pathogenic factors for both diseases. Low adiponectin,leptin,visfatin,and chemerin levels may induce or aggravate psoriasis by activating plasmacytoid dendritic cells or T cells,as demonstrated in in vitro experiments. However,in vitro experiments also have shown that visfatin may inhibit cardiomyocyte apoptosis.

Key words: psoriasis, cardiovascular disease, adipokine

CLC Number: